Humanin (10mg)
Cytoprotective Peptide
10mg1.450.000 ₫
Delivery method:
Single vial
1.450.000 ₫
Humanin pen (10mg)
1.885.000 ₫
Humanin is a 24-amino-acid peptide encoded inside the mitochondrial genome — one of the small family of mitochondrial-derived signalling peptides that includes MOTS-c. It acts as a cytoprotective and metabolic regulator, defending cells against oxidative stress, apoptosis and amyloid-induced toxicity. Plasma humanin levels decline with age and are altered in type-2 diabetes and Alzheimer's disease, suggesting a key role in metabolic, neuroprotective and longevity signalling. Researched outcomes include improved insulin sensitivity, neuronal survival under stress, cardioprotection in ischemia models and modulation of mitochondrial unfolded protein response. Of interest for users layering metabolic and cognitive longevity tools. Often stacked alongside SS-31 and MOTS-c. Typically dosed 2–3× per week in 8–12 week cycles.
Dosage
Start 1mg subcutaneous daily; after 1 week double to 2mg daily
Duration of effect
Daily dosing; benefits build over weeks (plasma half-life: ~30 minutes)
See full half-life table →Key Features
- Neuroprotection
- Anti-apoptotic
- Oxidative stress defense
- Metabolic support
Includes key details, half-life data, usage notes and research sources.
Usage Instructions
Subcutaneous injection as recommended. Consult a healthcare professional for protocols tailored to your goals.
Research Highlights
- Backed by scientific research
- Manufactured to pharmaceutical standards
- Used in clinical research settings
- Established safety profile
Safety Information
- •Consult your healthcare provider before use
- •Not intended for pregnant or nursing women
- •Store properly according to instructions
- •Report any adverse effects to your healthcare provider
Source: Journal of Translational Medicine (2019)
Clinical Research
Humanin is a mitochondrial-derived peptide with broad cytoprotective effects. Circulating humanin levels decline with age and are reduced in Alzheimer's disease and type 2 diabetes.
Read full studyAdditional Research
Source: Gong et al., Frontiers in Endocrinology (2014)
Comprehensive review of human age-related disease literature shows Humanin levels decline with age and inversely correlate with markers of mitochondrial dysfunction, type 2 diabetes, atherosclerosis, and Alzheimer's pathology.
Read full study